← Browse by Condition
Medical Condition

myocarditis

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for myocarditis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — myocarditis Clinical Trials

How many clinical trials are currently recruiting for myocarditis?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for myocarditis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocarditis?
myocarditis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocarditis clinical trial?
Eligibility criteria for myocarditis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
First Affiliated Hospital Xi'an Jiaotong University 1 trial
Chinese Academy of Medical Sciences, Fuwai Hospital 1 trial
University of Edinburgh 1 trial
Johann Wolfgang Goethe University Hospital 1 trial
Medical University of Warsaw 1 trial

Recruiting Clinical Trials

NCT06010199
Recruiting
Risk Stratification Value of Biomarkers in Patients With Myocarditis
Enrollment
1,000 pts
Location
China
Sponsor
First Affiliated Hospital Xi'a...
View Trial →
NCT07354646
Recruiting
The Application of T1 Mapping in Real-World
Enrollment
2,000 pts
Location
China
Sponsor
Chinese Academy of Medical Sci...
View Trial →
NCT06409585
Recruiting
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Enrollment
290 pts
Location
United Kingdom
Sponsor
University of Edinburgh
View Trial →
NCT04444128
Recruiting
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Enrollment
6,000 pts
Location
Germany
Sponsor
Johann Wolfgang Goethe Univers...
View Trial →
NCT04654988 Phase 4
Recruiting
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
Enrollment
100 pts
Location
Poland
Sponsor
Medical University of Warsaw
View Trial →

Related Conditions

heart failure (2) myocardial infarction mi (1) hypertrophic cardiomyopathy hcm (1) dilated cardiomyopathy dcm (1) arrhythmogenic cardiomyopathy (1) heart failure with preserved ejection fraction (1) hypertrophic cardiomyopathy (1) cardiac sarcoidosis (1) hypertensive heart disease (1) tako tsubo cardiomyopathy (1) arrhythmogenic right ventricular cardiomyopathy 1 (1) myocardial fibrosis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology